Candice Glover Performs “Somewhere” – AMERICAN IDOL SEASON 12

From the Musical West Side Story, Candice Glover performs the song “Somewhere.” Watch her third performance of the Top 3 performance night.

“Somewhere” performed by Candice Glover on American Idol
Buy now on iTunes:

Buy Top 3 Album Here: http://bit.ly/YvEYcG

Subscribe now for more American Idol clips: http://bit.ly/AmericanIdol_Subscribe

Tune in to AMERICAN IDOL Wednesday & Thursday 8/7c on FOX!

See more of American Idol on our official site: http://fox.tv/idol
Like American Idol on Facebook: http://fox.tv/idolFB
Follow American Idol on Twitter: http://fox.tv/idolTW
Add American Idol on Google+: http://fox.tv/idolG
Add American Idol on Tumblr: http://fox.tv/idolT
Add American Idol on Pinterest: http://fox.tv/idol_pin
Follow American Idol on Instagram: http://fox.tv/idol_I

Like FOX on Facebook: http://fox.tv/FOXTV_FB
Follow FOX on Twitter: http://fox.tv/FOXTV_Twitter
Add FOX on Google+: http://fox.tv/FOXPlus

Hosted by Ryan Seacrest, television’s No. 1 hit series empowers contestants and viewers to share their voices in deciding who will be America’s next singing superstar.

Every year, tens of thousands of hopefuls from across the nation audition for a shot at stardom. Idol Judges Mariah Carey, Randy Jackson, Nicki Minaj and Keith Urban are currently traveling across the country in search of the next AMERICAN IDOL. They narrow down the competitors to a select group of semifinalists who sing their hearts out each week in front of a studio audience and television viewers.

Candice Glover Performs “Somewhere” – AMERICAN IDOL SEASON 12

http://www.youtube.com/user/americanidol

GeoClickz - SEO Tools

Draco Financial Careers – Sales Job Posting

www.DracoFinancial.com

We are a Corporate Consulting office in search of dynamic individuals capable of working in a complex Business environment. Our Corporate Consulting firm creates market awareness for newly listed companies trading on the exchanges. Primary responsibilities are to effectively promote our client companies and their products through a phone based selling approach. Progressive promotion to senior Executive may occur through demonstration of sustained high performance and leadership.

Requirements:

Demonstrate ability to sell
Excellent problem solving, networking communication and organization skills
Interest in financial and investment markets
Demonstrate excellent work ethic and ability to multitask
Ability to understand and convey complex information
College degree not required, but welcome
Applicant must have the following characteristics:

Self starter
Determination to succeed
Must be aggressive
Needs to be likeable
Must be a proven closer
If you have these verifiable qualities, please forward resume. Willing to train the right individual.

Serious inquiries only.

____________________________________

Draco Financial Careers

Please send your resume for consideration to:

careers@dracofinancial.com

____________________________________

GeoClickz - SEO Tools

MACKLEMORE & RYAN LEWIS – THRIFT SHOP FEAT. WANZ

Thrift Shop on iTunes: http://itunes.apple.com/us/album/thri…
The Heist physical deluxe edition: http://www.macklemoremerch.com
The Heist digital deluxe on iTunes: http://itunes.apple.com/WebObjects/MZ…
The Heist on Amazon: http://amzn.com/B00908DDZM
The Heist in-stores NOW!

Credits:

VIDEO

Directed By Jon Jon Augustavo, Ryan Lewis, Ben Haggerty
Produced By Hollis Wong-Wear, Tricia Davis, Zach Quillen
Lead Grip: David Herberg
Grip Assistants: Josh Marten, Jay Neilson
Stylists: Annie Murphy, Alex Nordstrom

MUSIC

Written by Ben Haggerty
Produced by Ryan Lewis
Featuring Wanz
Additional vocals by Brooklyn Grinnell
Scratches by DV One

SPECIAL THANKS TO

Goodwill Outlet
Value Village Capitol Hill
Red Light Vintage
Fremont Vintage Mall
Unicorn/Narwhal
Northwest African American Museum

Sara Stapleton, JR Ewing and Inner City Empire, Faisal Jaswal, Clay Davis

GeoClickz - SEO Tools

The World’s End – Teaser Trailer

www.theworldsendmovie.co.uk

Follow us on Facebook – www.facebook.com/theworldsendmovieuk

Follow us on Twitter – www.twitter.com/TWEmovie
#Barmageddon

In The World’s End, 20 years after attempting an epic pub crawl, five childhood friends reunite when one of them becomes hellbent on trying the drinking marathon again. They are convinced to stage an encore by mate Gary King (Simon Pegg), a 40-year-old man trapped at the cigarette end of his teens, who drags his reluctant pals to their hometown and once again attempts to reach the fabled pub – The World’s End. As they attempt to reconcile the past and present, they realise the real struggle is for the future, not just theirs but humankind’s. Reaching The World’s End is the least of their worries.

GeoClickz - SEO Tools

ENDER’S GAME — Trailer

Stay Informed: IF-Sentinel.com
Become a Fan on Facebook: Facebook.com/EndersGame
Follow on Twitter: Twitter.com/EndersGameMovie
Follow on Google+: Google.com/+EndersGame

Based on the best-selling, award winning novel, ENDER’S GAME is an epic adventure starring Asa Butterfield, Hailee Steinfeld, Ben Kingsley, Viola Davis, with Abigail Breslin and Harrison Ford.

GeoClickz - SEO Tools

TherapeuticsMD Reports First Quarter 2013 Financial Results

Draco Financial Client
www.DracoFinancial.com/txmd

See SEC Filing

BOCA RATON, Fla.–(BUSINESS WIRE)–TherapeuticsMD, Inc. (NYSE MKT:TXMD), a women’s healthcare company focused on developing and commercializing products targeted exclusively for women, today announced financial results for the three months ended March 31, 2013.

“With our newly strengthened balance sheet, NYSE MKT listing, and strong portfolio of bioidentical hormone therapy product candidates, we believe TherapeuticsMD is well positioned for success as we execute our strategy to become a leader in the women’s healthcare field”

First Quarter and Subsequent Highlights:

• Net revenue for the quarter ended March 31, 2013 was $1.5 million compared with approximately $722,000 in the first quarter of 2012;
• Net loss improved to $6.4 million for the quarter ended March 31, 2013 compared with a net loss of $13.3 million in the first quarter of 2012;
• Cash and cash equivalents were $38.8 million at March 31, 2013, compared with $1.6 million at December 31, 2012;
• The Company generated approximately $48.5 million in net proceeds through the issuance and sale of approximately 31.4 million shares of TXMD common stock in an underwritten public offering, which includes net proceeds of approximately $3.1 million from the issuance and sale of approximately 2.0 million shares to cover over-allotments; and
• TXMD common stock commenced trading on the NYSE MKT on April 23, 2013.

“With our newly strengthened balance sheet, NYSE MKT listing, and strong portfolio of bioidentical hormone therapy product candidates, we believe TherapeuticsMD is well positioned for success as we execute our strategy to become a leader in the women’s healthcare field,” said Robert G. Finizio, Chief Executive Officer.

“We look forward to initiating pivotal Phase III clinical trials with two of our bioidentical hormone therapy product candidates, 17β estradiol/ progesterone combination and lower dose oral progesterone, which we believe can achieve equivalent efficacy at lower doses of active compound and lower cost to patients versus currently available products. We expect to file an IND application for an additional hormone therapy candidate, a novel estradiol suppository, later this year.”

First Quarter Results

Net revenue for the first quarter of 2013 totaled $1.5 million, compared with net revenue of approximately $722,000 for the year ago quarter. The increase of approximately $815,000, or 113%, was directly attributable to an increase in sales territories, sales people and new prescription products. Cost of goods sold increased by approximately $44,000, or 13%, for the three months ended March 31, 2013 compared with the prior year quarter. Research and development expenses increased to $1.6 million during the first quarter of 2013 compared with approximately $400,000 in the first quarter of 2012, due to costs incurred for the development of our new hormone replacement therapy and prescription prenatal products. Selling, general and administrative expenses increased to $4.5 million during the first quarter of 2013 compared with $2.8 million in the first quarter of 2012. As a result, our operating loss was $4.9 million in the first quarter of 2013 compared with $2.9 million in the first quarter of 2012.

Other non-operating expenses decreased by approximately $9.0 million for the first quarter of 2013 compared with the comparable quarter in 2012. This decrease resulted primarily from a loss on extinguishment of debt incurred during 2012, partially offset by an increase in amortization of debt discount of approximately $1.0 million and amortization of financing costs of approximately $300,000.

As a result, net loss for the first quarter of 2013 was $6.4 million, or $0.06 per basic and diluted share, compared with a net loss of $13.3 million, or $0.16 per basic and diluted share, in the first quarter of 2012.

Cash and cash equivalents increased to $38.8 million at March 31, 2013.

About Hormone Therapy

Hormone therapy (HT) is the administration of hormones to supplement a lack of naturally occurring hormones. HT options include natural, bioidentical, and non-bioidentical (conjugated) hormones. HT is projected to be the largest growth segment in the overall women’s health market. The potential market for pharmacy-compounded, bioidentical hormone therapy products is estimated to be approximately $1.5 billion per year.

About TherapeuticsMD, INC.

TherapeuticsMD, Inc. is a women’s healthcare company focused on developing and commercializing products targeted exclusively for women. We manufacture and distribute branded and generic prescription prenatal vitamins, as well as over-the-counter (OTC) vitamins and cosmetics, under our vitaMedMD^® and BocaGreenMD™ brands. We are currently developing advanced hormone therapy pharmaceutical products designed to alleviate the symptoms of and reduce the health risks resulting from menopause-related hormone deficiencies. We are also evaluating various other potential indications for our hormone technology, including oral contraception, preterm birth, vulvar and vaginal atrophy, and premature ovarian failure. More information is available at the following websites: www.therapeuticsmd.com,www.vitamedmd.com, www.vitamedmdrx.com, and www.bocagreenmd.com.

vitaMedMD^® is a registered trademark and TherapeuticsMD™ and BocaGreenMD™ are trademarks of TherapeuticsMD, Inc.

Except for the historical information contained herein, the matters set forth in this press release, including statements regarding the Company’s belief that it is well positioned for success as it executes its strategy to become a leader in the women’s healthcare field, the Company’s expectations with respect to the timing of the Company’s planned clinical trials, the Company’s belief that it can achieve equivalent efficacy at lower doses of active compound and lower cost to patients versus currently available products, and the Company’s expectations with respect to the timing of filing an IND application, are forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially, including but not limited to: timely and successful completion of clinical studies and the results thereof; challenges and costs inherent in product marketing; the risks and uncertainties associated with economic and market conditions; risks and uncertainties associated with TherapeuticsMD’s business and finances in general; and other risks detailed in TherapeuticsMD’s filings with the U.S. Securities and Exchange Commission including its annual report on Form 10-K filed on March 12, 2013, reports on Form 10-Q and Form 8-K, and other such filings. These forward-looking statements are based on current information that may change. Investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. All forward-looking statements are qualified in their entirety by this cautionary statement, and TherapeuticsMD undertakes no obligation to revise or update any forward-looking statement to reflect events or circumstances after the issuance of this press release.

GeoClickz - SEO Tools

Draco Financial Investor Relations is a leading financial Investor Relations firm specializing in small cap stock investing which trade on the OTC markets.

Draco Financial LLC – Corporate Consulting and Investor Relations

Draco Financial Investor Relations is a leading financial Investor Relations firm dedicated to profiling emerging growth opportunities to the investment community, specializing in small cap stock investing which trade on the OTC markets.

GeoClickz - SEO Tools

Swedish House Mafia – Don’t You Worry Child ft. John Martin

Swedish House Mafia was a Swedish electronic dance music trio consisting of three house disc jockeys and producers: Axwell, Steve Angello, and Sebastian Ingrosso. The group officially formed in late 2008. The supergroup placed at number ten on the DJ Magazine Top 100 DJ Poll 2011[1] and have been called “the faces of mainstream progressive house music.”[2] On June 24, 2012, the group announced via their website that their current tour would be their last together.[3] They have officially broken up as of their final appearance at the Ultra Music Festival on March 24, 2013.

GeoClickz - SEO Tools

Imagine Dragons – It’s Time – Peter Hollens & Tyler Ward (A cappella)

GeoClickz - SEO Tools

Empire Of The Sun – Alive

Empire of the Sun have released their new music video for the track “Alive”. The track will be on their new album “Ice on the Dune”, which is scheduled for a June 2013 release. The video is a futuristic costume spectacle worth taking a look at.

GeoClickz - SEO Tools